MedTrace Logo

Molecular Imaging of Breast Cancer With Breast PET/CT

NCT00584753 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2013-01-14

No results posted yet for this study

Summary

This study is a feasibility study to determine if a combined breast PET/CT scanner can image malignant functional activity while determining anatomical structure in the same clinical setting for patients with breast cancer. End-points of this study are whether women will accept the imaging position and timing, and whether functional properties of breast cancer can be imaged with this device. The secondary purpose of this study is to explore protocol parameters with a view to optimizing imaging performance whilst minimizing patient discomfort. Imaging results will be compared to histological samples to determine ground truth.

Conditions

Interventions

RADIATION

Positron emission tomography and computed tomography

Positron emission tomography and computed tomography

RADIATION

Positron emission tomography and computed tomography

Positron emission tomography and computed tomography

RADIATION

Positron emission tomography and computed tomography

Positron emission tomography and computed tomography

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Ramsey Badawi, PhD · University of California, Davis

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00584753 on ClinicalTrials.gov